...
首页> 外文期刊>Endocrine. >Oral L-thyroxine liquid versus tablet in patients with hypothyroidism without malabsorption: a prospective study
【24h】

Oral L-thyroxine liquid versus tablet in patients with hypothyroidism without malabsorption: a prospective study

机译:甲状腺功能低下且无吸收不良的患者口服左旋甲状腺素液与片剂:一项前瞻性研究

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

No consistent data are present in literature about the effectiveness of levothyroxine (l-T4) liquid formulation in patients without malabsorption. The aim of this study is to compare the effectiveness of l-T4 liquid formulation, with l-T4 tablets, in hypothyroid patients without malabsorption or drug interference. One hundred and fifty two patients were recruited. Patients were switched from the l-T4 therapy in tablets, to liquid l-T4 at the same dosage, 30 min before breakfast. Serum thyrotropic hormone (TSH), free thyroxine (FT4), and free triiodothyronine (FT3) were re-evaluated after 1-3 months (first control) and 5-7 months (second control) from the switch. TSH values significantly declined with respect to the basal value after the switch to liquid l-T4 both at the first control (P < 0.05) and at the second control (P < 0.01); FT4 and FT3 levels were not significantly changed. We show that liquid l-T4 is more effective than l-T4 tablet in controlling TSH levels in hypothyroid patients without malabsorption, gastric disorders, or drug interference.
机译:在没有吸收不良的患者中,关于左甲状腺素(1-T4)液体制剂有效性的文献中没有一致的数据。这项研究的目的是比较l-T4液体制剂与l-T4片剂在没有吸收不良或药物干扰的甲状腺功能减退患者中的有效性。招募了152名患者。在早餐前30分钟将患者从片剂中的1-T4治疗改为相同剂量的液体1-T4。转换后1-3个月(第一个对照)和5-7个月(第二个对照)后,重新评估了血清促甲状腺激素(TSH),游离甲状腺素(FT4)和游离三碘甲状腺素(FT3)。在第一个对照(P <0.05)和第二个对照(P <0.01)下,TSH值均相对于转换为液体1-T4后的基础值显着下降; FT4和FT3水平没有明显变化。我们显示在控制甲状腺功能减退患者的TSH水平方面,液体l-T4比l-T4片剂更有效,而不会吸收不良,胃部疾病或药物干扰。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号